(20R)-Ginsenoside Rh1CAS# 80952-71-2 |
- Ginsenoside Rh1
Catalog No.:BCN1069
CAS No.:63223-86-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 80952-71-2 | SDF | Download SDF |
| PubChem ID | 157710 | Appearance | Powder |
| Formula | C36H62O9 | M.Wt | 638.9 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R,3R,4S,5S,6R)-2-[[(6R,8R,10R,12S,14S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
| SMILES | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)O)C | ||
| Standard InChIKey | RAQNTCRNSXYLAH-VLBLZPEBSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | (20R)-Ginsenoside Rh1 exhibits various pharmacological activities including vasorelaxation, antioxidation, anti-inflammation, and anticancer. |
| In vitro | Pharmacological Study on Panax ginseng C.A. MEYER V. : Effects of Red Ginseng on the Experimental Disseminated Intravascular Coagulation (4). On Ginsenoside-Rg3, Rh1 and Rh2[Reference: WebLink]Japanese Journal of Pharmacognosy, 1985, 39:123-5.
|
| Structure Identification | Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3910-7.Chemical constituents from processed rhizomes of Panax notoginseng.[Pubmed: 24558875]
|
(20R)-Ginsenoside Rh1 Dilution Calculator
(20R)-Ginsenoside Rh1 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.5652 mL | 7.826 mL | 15.6519 mL | 31.3038 mL | 39.1298 mL |
| 5 mM | 0.313 mL | 1.5652 mL | 3.1304 mL | 6.2608 mL | 7.826 mL |
| 10 mM | 0.1565 mL | 0.7826 mL | 1.5652 mL | 3.1304 mL | 3.913 mL |
| 50 mM | 0.0313 mL | 0.1565 mL | 0.313 mL | 0.6261 mL | 0.7826 mL |
| 100 mM | 0.0157 mL | 0.0783 mL | 0.1565 mL | 0.313 mL | 0.3913 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Zingibroside R1
Catalog No.:BCN3433
CAS No.:80930-74-1
- Gnetumontanin B
Catalog No.:BCN3756
CAS No.:809237-87-4
- Concanamycin A
Catalog No.:BCC3919
CAS No.:80890-47-7
- 3,22-Dihydroxyolean-12-en-29-oic acid
Catalog No.:BCN1347
CAS No.:808769-54-2
- Pyracrenic acid
Catalog No.:BCN7455
CAS No.:80832-44-6
- FG-4592 (ASP1517)
Catalog No.:BCC2227
CAS No.:808118-40-3
- 1-Hydroxycanthin-6-one
Catalog No.:BCN4347
CAS No.:80787-59-3
- 3-Acetylyunaconitine
Catalog No.:BCN7640
CAS No.:80787-51-5
- Tectorigenin sodium sulfonate
Catalog No.:BCN8161
CAS No.:807636-25-5
- S-2-Benzothiazolyl2-amino-alpha-(methoxyimino)-4-thiazolethiolacetate
Catalog No.:BCC9138
CAS No.:80756-85-0
- H-Arg(Mtr)-OH.1/2H2O
Catalog No.:BCC2863
CAS No.:80745-10-4
- Z-Arg(Mtr)-OH.CHA
Catalog No.:BCC3062
CAS No.:80745-09-1
- 20R-Ginsenoside Rg2
Catalog No.:BCN2554
CAS No.:80952-72-3
- 6-Amino-1-naphthalenesulfonic acid
Catalog No.:BCC8758
CAS No.:81-05-0
- Musk ketone
Catalog No.:BCN8357
CAS No.:81-14-1
- 2-Amino-1-naphthalenesulfonic acid
Catalog No.:BCC8519
CAS No.:81-16-3
- Taurocholic acid
Catalog No.:BCN6954
CAS No.:81-24-3
- Cholic acid
Catalog No.:BCN1286
CAS No.:81-25-4
- Sennoside A
Catalog No.:BCN1002
CAS No.:81-27-6
- Purpurin
Catalog No.:BCN3477
CAS No.:81-54-9
- Warfarin
Catalog No.:BCC5221
CAS No.:81-81-2
- Rhodamine B
Catalog No.:BCN7215
CAS No.:81-88-9
- 4-Hydroxy-4-(methoxycarbonylmethyl)cyclohexanone
Catalog No.:BCN1346
CAS No.:81053-14-7
- Methyl 4-prenyloxycinnamate
Catalog No.:BCN7520
CAS No.:81053-49-8
[Chemical constituents from processed rhizomes of Panax notoginseng].[Pubmed:24558875]
Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3910-7.
To investigate the chemical constituents of the processed rhizomes of Panax notoginseng, their 70% ethanol extract was chromatographed on macroporous resin (SP825), silica gel, RP-C18 and semi-preparative HPLC to afford compounds 1-23. On the basis of physicochemical properties and spectral data analysis, their structures were identified to be 6'-O-Acetylginsenoside Rh1 (1), ginsenoside RK3 (2), ginsenoside Rh4 (3), 20S-ginsenoside Rg3 (4), ginsenoside Rk1 (5), 20R-ginsenoside Rg3 (6), ginsenoside Rg5 (7), ginsenoside F2 (8), 20S-ginsenoside Rh1 (9), 20R-ginsenoside Rh1 (10), gypenoside X VII (11), notoginsenoside Fa, (12), ginsenoside Ra3 (13), ginsenoside Rg1 (14), ginsenoside Re (15), notoginsenoside R2 (16), ginsenoside Rg2 (17), notoginsenoside R1 (18), ginsenoside Rd (19), ginsenoside Rb1 (20), notoginsenoside D (21), notoginsenoside R4 (22) and ginsenoside Rb2 (23), respectively. Among them, compound 1 was isolated from P. notoginseng for the first time, and compounds 4, 6, 8 and 11 were isolated from the processed P. notoginseng for the first time. According to the fingerprint profiles of raw and processed P. notoginseng, the putative chemical conversion pathways of panoxatriol and panoxadiol compounds in the processing procedure was deduced, and the results revealed the main reactions to be dehydration and glycosyl hydrolysis.
